Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Motorcyclist Killed in Crash at Orange Avenue and Highway 137


2 Vehicles Collide in Fatal Corcoran Accident

Corcoran, CA (March 24, 2020) – A motorcyclist was killed in a crash in Corcoran. The fatal accident occurred on the evening of March 24 at Orange Avenue and Highway 137.

A motorcycle and another vehicle were involved in a crash. The motorcyclist died at the accident scene.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Corcoran

#93212


April 13, 2020

3 Killed in Crash on Poindexter Avenue

Vehicle Hits Tree, Catches Fire in Fatal Moorpark Accident...


October 10, 2019

Crash on Highway 50 Near Stockton Boulevard Causes Minor Injuries

3 Vehicles Involved in Sacramento Accident Sacramento, CA (October 9, 2019) –...


January 28, 2020

Man Killed in Crash at Eighth Street East and Napa Road

Abdulhadi Awad Arrested for DUI in Fatal Sonoma Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.